Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Pevaryl Foaming solution*

Pevaryl Foaming solution* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Janssen
Responsible Party Cilag AG
Origin Switzerland
Manufacturer Cilag AG
Origin Switzerland
ATC D01AC03

Your comment will appear shortly after approval

Pevaryl Foaming solution* :

Revision Date : 01/06/2015


Effect Frequency
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Application site swelling Uncommon
Application site vesicles Very rare
Burn Common
Dermatitis contact Very rare
Desquamation Very rare
Discomfort Uncommon
Erythema Uncommon
Exanthema Very rare
Hypersensitivity reactions Very rare
Pain Common
Pruritus Common
Urticaria Very rare

Different Units By MoH Code

Revision Date : 01/05/2011

Pevaryl Foaming solution*  MoH 1919 :
Form Cutaneous foam
Packaging Sachets (paper / Al / PE)
Package Size 3x10g
Strength 1%
NSSF ✘
Quarantine ✘
Reg. Number 26471
Submission date 01/01/1974
Registration Year 1974
Archived Date 2014


Price Comparison

● Country: New Zealand
● Package Size: 3 ea
● Exfactory Price: 17.23 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/01/2019
● Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info